Disc Medicine, Inc.
74.51USD
-0.5200 (-0.69%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on IRON.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$1.71▲ | -$1.86 | 1 | 1 |
| Next quarter | -$1.74▲ | -$1.92 | 1 | 1 |
| Current year | -$6.57▲ | -$7.16 | 2 | 0 |
| Next year | -$6.92▲ | -$7.59 | 2 | 0 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$1.77 | -$1.54 | +0.23 (+12.9%) |
| 2026-03-31 | -$1.73 | -$1.65 | +0.08 (+4.4%) |
| 2025-12-31 | -$1.7 | -$1.62 | +0.08 (+4.9%) |
| 2025-09-30 | -$1.46 | -$1.77 | -0.31 (-20.9%) |
85 ratings from 12 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Morgan Stanley | Maintained | Overweight | $90 $92 | Oct 20, 2026 |
| Truist Securities | Maintained | Buy | $83 $115 | Oct 20, 2026 |
| Wells Fargo | Maintained | Overweight | $86 $124 | Oct 20, 2026 |
| Wedbush | Maintained | Outperform | $100 $110 | Oct 20, 2026 |
| BMO Capital | Maintained | Outperform | $100 $120 | Oct 19, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $125 $170 | Oct 19, 2026 |
| Wells Fargo | Maintained | Overweight | $79 $86 | Sep 16, 2026 |
| Wedbush | Reiterated | Outperform | $100 | Sep 10, 2026 |
| Wedbush | Maintained | Outperform | $88 $100 | Sep 2, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $118 $120 | Aug 6, 2026 |
| Morgan Stanley | Maintained | Overweight | $80 $85 | Jun 16, 2026 |
| Wedbush | Reiterated | Outperform | $88 | Jun 10, 2026 |
| Morgan Stanley | Maintained | Overweight | $75 $80 | May 14, 2026 |
| Wells Fargo | Maintained | Overweight | $78 $79 | Mar 2, 2026 |
| Truist Securities | Maintained | Buy | $114 $83 | Feb 27, 2026 |
| Stifel | Maintained | Buy | $125 $110 | Feb 17, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $153 $125 | Feb 17, 2026 |
| BMO Capital | Maintained | Outperform | $120 $100 | Feb 17, 2026 |
| Wedbush | Maintained | Outperform | $110 $88 | Feb 17, 2026 |
| Wells Fargo | Maintained | Overweight | $109 $78 | Feb 17, 2026 |
| Wells Fargo | Maintained | Overweight | $91 $109 | Dec 16, 2025 |
| Truist Securities | Maintained | Buy | $86 $114 | Nov 10, 2025 |
| Morgan Stanley | Maintained | Overweight | $90 $115 | Oct 30, 2025 |
| Raymond James | Maintained | Strong Buy | $89 $108 | Oct 17, 2025 |
| Cantor Fitzgerald | Maintained | Overweight | $132 $153 | Oct 17, 2025 |
138 filings from 13 insiders · 14 buy / 16 sell over 6m
Officers and directors of IRON, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Bitterman KevinDirector | Sellindirect | 266 | $80.23 | $21k | Oct 21, 2026 |
| Bitterman KevinDirector | Sellindirect | 11.5k | $80.23 | $920k | Oct 21, 2026 |
| Bitterman KevinDirector | Sellindirect | 13.8k | $80.23 | $1.11M | Oct 21, 2026 |
| Bitterman KevinDirector | Sellindirect | 55 | $79.95 | $4k | Oct 20, 2026 |
| Bitterman KevinDirector | Sellindirect | 2.4k | $79.95 | $191k | Oct 20, 2026 |
| Bitterman KevinDirector | Sellindirect | 2.9k | $79.95 | $229k | Oct 20, 2026 |
| Bitterman KevinDirector | Sellindirect | 5.9k | $79.97 | $475k | Oct 19, 2026 |
| Bitterman KevinDirector | Sellindirect | 4.9k | $79.97 | $395k | Oct 19, 2026 |
| Bitterman KevinDirector | Sellindirect | 115 | $79.97 | $9k | Oct 19, 2026 |
| Quisel John DDirector; Officer, Chief Executive Officer | Exercise | 36.0k | $1.01 | $36k | Sep 15, 2026 |
| Quisel John DDirector; Officer, Chief Executive Officer | ExerciseStock Option (Right to Buy) | 36.0k | — | — | Sep 15, 2026 |
| Bitterman KevinDirector | Exercise | 7.1k | $45.69 | $326k | Sep 11, 2026 |
| Bitterman KevinDirector | Exercise | 10.0k | $38.85 | $389k | Sep 11, 2026 |
| Bitterman KevinDirector | Exercise | 10.0k | $50.86 | $509k | Sep 11, 2026 |
| Bitterman KevinDirector | Sell | 27.1k | $70.11 | $1.90M | Sep 11, 2026 |
| Bitterman KevinDirector | ExerciseStock Option (Right to Buy) | 7.1k | — | — | Sep 11, 2026 |
| Bitterman KevinDirector | ExerciseStock Option (Right to Buy) | 10.0k | — | — | Sep 11, 2026 |
| Bitterman KevinDirector | ExerciseStock Option (Right to Buy) | 10.0k | — | — | Sep 11, 2026 |
| Bitterman KevinDirector | Sellindirect | 912 | $79.96 | $73k | Sep 4, 2026 |
| Bitterman KevinDirector | Sellindirect | 759 | $79.96 | $61k | Sep 4, 2026 |
No analyst notes on IRON yet.
Analyst Ratings
12 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 12 | 0 | 0 | 0 | Buy1.92 |
| 1 mo ago | 1 | 12 | 0 | 0 | 0 | Buy1.92 |
| 2 mo ago | 1 | 12 | 0 | 0 | 0 | Buy1.92 |
| 3 mo ago | 1 | 12 | 0 | 0 | 0 | Buy1.92 |
Members whose judged calls on IRON have played out most reliably.
No settled calls on IRON yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice